Evaluation of the β-Lactamase Disk Test Method in the Detection of Extended-Spectrum-β-Lactamases in Clinical Isolates of Multidrug-Resistant Pseudomonas aeruginosa

Document Type: Original Article

Authors

1 Assistant Professor, Department of Microbiology, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

2 Assistant Professor, Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

3 Professor, Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

4 Associate Professor, Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background & Aims: The production of extended-spectrum-β-lactamases (ESBLs) is the main mechanism of resistance to β-lactam antibiotics. The outbreak of isolates simultaneously possessing several resistance mechanisms to β-lactam antibiotics caused a decrease in sensitivity of the confirmatory tests for ESBL. The aim of this study was the evaluation of the β-lactamase disk test method in the detection of ESBLs in clinical isolates of multidrug-resistant Pseudomonas aeruginosa.
Methods: A total of 100 multidrug-resistant P. aeruginosa isolates were recovered from burn patients. The sensitivity of the isolates to different antibiotics was determined using the standard disk diffusion method. ESBL-producing isolates were detected through the combination disk test with clavulanic acid, double disk synergy test, and β-lactamase disk test. Carbapenemase-producing isolates were detected using the Modified Hodge Test (MHT). The ESBLs genes (blaTEM, blaOXA, blaPER, blaSHV, blaCTX-M and blaPSE) were determined through polymerase chain reaction (PCR).
Results: All isolates were multidrug resistant. Only 3 isolates were detected as ESBL-producing isolates through combination disk test. No ESBL-producing isolates were detected through double disk synergy test. Among the 100 studied isolates, 87% were detected as ESBL-producing isolates and 68% as carbpenemase-producing isolates through β-lactamase disk test. . The prevalence of bla
TEM
, bla
OXA
, and bla
PER
among isolates were 97%, 61%, and 13%, respectively. All isolates were negative for bla
SHV
, bla
PSE
, and bla
CTX-M
.
Conclusion: According to the results obtained in this study, the β-lactamase disk test is suitable for the detection of ESBLs in multidrug resistant isolates. However, further investigation is required.

Keywords


  1. Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol 2010; 300(6): 371-9.
  2. Poole K. Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2011; 2: 65.
  3. Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother 2010; 54(3): 969-76.
  4. Falagas ME, Karageorgopoulos DE. Extended-spectrum beta-lactamase-producing organisms. J Hosp Infect 2009; 73(4): 345-54.
  5. Sundin D. Hidden beta-lactamases in the enterobacteriaceae – dropping the extra disks for detection, part II. Clinical Microbiology Newsletter 2009; 31(7): 47-52.
  6. Willems E, Verhaegen J, Magerman K, Nys S, Cartuyvels R. Towards a phenotypic screening strategy for emerging beta-lactamases in Gram-negative bacilli. Int J Antimicrob Agents 2013; 41(2): 99-109.
  7. Doi Y, Paterson DL. Detection of plasmid-mediated class C beta-lactamases. Int J Infect Dis 2007; 11(3): 191-7.
  8. Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev 2009; 22(1): 161-82, Table.
  9. Mahon CR, Lehman D, Manuselis G. Textbook of diagnostic microbiology. 3rd ed. Philadelphia, PA: Saunders Elsevier; 2007.
  10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement [Online]. [cited 2012 Jan]; Available from: URL: http://antimicrobianos.com.ar/ATB/wp-content/uploads/2012/11/M100S22E. p. 58, 60, 114-22.
  11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement [Online]. [cited Jun 2014]; Available from: URL: http://ncipd.org/control/images/NCIPD_docs/CLSI_M100-S24.pdf
  12. Neyestanaki DK, Mirsalehian A, Rezagholizadeh F, Jabalameli F, Taherikalani M, Emaneini M. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients. Burns 2014; 40(8): 1556-61.
  13. Martine E, Escobar Pérez J, Márquez C, Vilacoba E, Centró D, Leal AL, et al. Emerging and existing mechanisms co-operate in generating diverse ß-lactam resistance phenotypes in geographically dispersed and genetically disparate Pseudomonas aeruginosa strains. Journal of Global Antimicrobial Resistance 2013; 1(3): 135-42.
  14. Poole K. Resistance to beta-lactam antibiotics. Cell Mol Life Sci 2004; 61(17): 2200-23.
  15. Jacoby GA, Munoz-Price LS. The new ß-Lactamases. N Engl J Med 2005; 352(4): 380-91.
  16. Kalantar D, Jabalameli F, Emaneini M. The modified Hodge test for identification of Klebsiella pneumoniae carbapenemase producing isolates. Burns 2013; 39(2): 370-1.
  17. Kalantar D, Mansouri S. Emergence of multiple β-lactamases produced by Escherichia coli clinicalisolates from hospitalized patient in Kerman, Iran. Jundishapur J Microbiol 2010; 3(4): 137-45.
  18. Mansouri S, Kalantar D, Asadollahi P, Taherikalani M, Emaneini M. Characterization of Klebsiella pneumoniae strains producing extended spectrum beta-lactamases and AMPC type beta-lactamases isolated from hospitalized patients in Kerman, Iran. Roum Arch Microbiol Immunol 2012; 71(2): 81-6.
  19. Mansouri S, Neyestanaki DK, Shokoohi M, Halimi S, Beigverdi R, Rezagholezadeh F, et al. Characterization of AmpC, CTX-M and MBLs types of ß-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli producing Extended Spectrum ß-lactamases in Kerman, Iran. Jundishapur J Microbiol 2014; 7(2): e8756.
  20. Song W, Jeong SH, Kim JS, Kim HS, Shin DH, Roh KH, et al. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis. Diagn Microbiol Infect Dis 2007; 57(3): 315-8.
  21. Rodriguez-Martinez JM, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009; 53(11): 4783-8.